CD34 and myelodysplastic syndrome: Abnormal upregulation of PD-L1, PD-L2, PD-1, and cytotoxic T-lymphocyte antigen 4 (CTLA4) in CD34+ cells in MDS patients compared to healthy controls has been reported, suggesting that as a potential mechanism triggering HR-MDS (239).